Amalgamation Corporate Action
Ambuja Cements Receives BSE and NSE Clearance for Proposed Amalgamation of ACC with Ambuja Cements
NSE
AMBUJACEM
BSE
500425
Ambuja Cements Limited has received observation letters carrying “No Adverse Observations” from BSE and “No Objection” from NSE for the proposed amalgamation of ACC Limited with Ambuja Cements Limited. The development marks a key regulatory milestone for the merger, allowing the companies to proceed with filing the scheme before the National Company Law Tribunal (NCLT), subject to shareholder, creditor, statutory, and regulatory approvals.
PRICE-SENSITIVE TRIGGER
Event: Receipt of stock exchange observation letters for the proposed merger of ACC Limited into Ambuja Cements Limited.
Type: Merger / Amalgamation Corporate Action
Impact: Positive
Immediate Effect: The merger proposal has cleared an important stock exchange review stage, enabling the companies to move forward with the NCLT approval process and subsequent shareholder and creditor approvals.
Key Metrics:
- No new financial metrics disclosed in the filing.
- No revised merger consideration disclosed.
- No revenue, EBITDA, PAT, margin, QoQ, YoY, or segment performance data provided in this communication.
Highlight:
- BSE and NSE have issued regulatory observation letters allowing the proposed ACC–Ambuja amalgamation process to advance to the next approval stage.
What Happened ?
Ambuja Cements informed stock exchanges that it has received observation letters from BSE and NSE regarding the proposed Scheme of Amalgamation of ACC Limited with Ambuja Cements Limited.
BSE issued an observation letter containing “No Adverse Observations” while NSE issued a “No Objection” letter on June 4, 2026. These observations were issued following SEBI’s review and comments on the proposed scheme.
The transaction remains subject to approvals from the National Company Law Tribunal, shareholders, creditors, and other applicable statutory and regulatory authorities before becoming effective.
Key Details
Stock Exchange Clearance for ACC–Ambuja Merger Scheme:
- Proposed transaction involves amalgamation of ACC Limited into Ambuja Cements Limited.
- Ambuja will act as the amalgamated company while ACC will be the amalgamating company.
- BSE issued an observation letter with “No Adverse Observations”.
- NSE issued an observation letter with “No Objection”.
- Observation letters were received on June 4, 2026.
- The scheme was originally approved by the boards of the companies in December 2025.
- SEBI observations have been incorporated into the stock exchange review process.
- Companies must disclose all ongoing adjudication, recovery, prosecution, and enforcement proceedings before seeking final approvals.
- Any proposed shares issued under the scheme must be in dematerialized form.
- Observation letters remain valid for six months from the date of issuance.
- The scheme must be filed before NCLT within the validity period.
- Any material changes to the scheme after filing are restricted unless mandated by regulators, authorities, or the tribunal.
- Additional information submitted after filing must be hosted on company websites and stock exchange platforms.
- Companies must provide extensive shareholder disclosures including valuation methodology, fairness opinion, financial information, shareholding impact, and cost-benefit analysis before shareholder voting.
Note:
- The receipt of stock exchange observations removes a significant regulatory hurdle and moves the merger process into the judicial and shareholder approval phase, which is critical for implementation of the consolidation strategy.
Risk Analysis
Summary:
- While the stock exchange review stage has been completed, the amalgamation remains subject to multiple approvals and procedural requirements before becoming effective.
Key Risks:
- NCLT approval is still pending.
- Shareholder approval remains required.
- Creditor approvals may be required where applicable.
- Regulatory authorities may impose additional conditions.
- Any adverse developments in pending legal or enforcement proceedings could affect the approval process.
- Failure to complete approvals within the observation letter validity period may require fresh regulatory processes.
- The scheme cannot be materially modified without regulatory or tribunal direction.
Worst Case Scenario:
- If required approvals are delayed, challenged, or denied, the proposed amalgamation could be postponed, modified, or fail to become effective.
Risk Level: Medium
Company Commentary
- Ambuja Cements has received observation letters from both BSE and NSE.
- The company has received “No Adverse Observations” from BSE.
- The company has received “No Objection” from NSE.
- The proposed amalgamation remains subject to statutory, regulatory, shareholder, creditor, and tribunal approvals.
- Observation letters will be made available on the company’s website.
- The company has informed stock exchanges of this regulatory milestone in the merger process.
Official Exchange Filing: Ambuja Cements Limited